Otolaryngology Doctors in San Juan, PR Accepting Medicare

28 Otolaryngology doctors found. Showing 21 - 28

Pedro J Rullan Marin, MD, FACS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 735 Ave Ponce De Leon, Torre Auxilio Mutuo # 512, San Juan, PR 00917 Phone: 787-751-1910    Fax: 787-282-7131

Ralph Perez Villamil, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 60 Washington St, Apartment 803, San Juan, PR 00907 Phone: 787-725-3903    Fax: 787-723-3448

Dr. Mariana Judith Ortiz Martinez, M. D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1789 Carretera 21, Torre Hospital Metropolitano Suite 309, San Juan, PR 00921 Phone: 787-706-1315    Fax: 787-781-5923

Jose M Bird, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: Cond. Torre De Auxilio Mutuo, Suite 711 Ave. Ponce De Leon # 735, San Juan, PR 00917 Phone: 787-765-2563    Fax: 787-274-1886

Dr. Gabriel Hernandez Martin, M.D. Otolaryngology - Otology & Neurotology Medicare: Accepting Medicare Assignments Practice Location: Ashford Medical Tower Suite 805, 29 Washington Street, San Juan, PR 00907 Phone: 787-721-6380

Sara Ismari Perez, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 200 Ave Winston Churchill, Suite 202, San Juan, PR 00926 Phone: 787-772-8384    Fax: 787-765-7864

Dr. Miguel R. Garraton - Martin, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 369 Ave. De Diego, Torre Medica San Francisco Suite 506, San Juan, PR 00923 Phone: 787-756-8126

Edgar Fernando Del Toro Diez, Otolaryngology Medicare: Medicare Enrolled Practice Location: Department Of Otolaryngology Head And Neck Surgery, University Of Puerto Rico- School Of Medicine, San Juan, PR 00936 Phone: 787-758-2525

News Archive

World Heart Federation publishes position statement on rheumatic fever, rheumatic heart disease

The World Heart Federation has published a new position statement outlining the five key strategic targets required to meet its strategic goal for rheumatic heart disease - a 25% reduction in premature deaths from rheumatic fever and RHD among individuals aged <25 years by the year 2025.

Free chlamydia testing in pharmacies - questions need addressing

The British Government's pilot scheme offering free chlamydia testing in pharmacies is to be applauded but a number of issues need to be resolved if it is to be a success, concludes an editorial in this week's issue of The Lancet.

A tumor marker Ca 19-9 in diabetics can lead to misdiagnosis of pancreatic cancer

Diabetes is increasing all over the world along with the increase of obesity and associated diseases and is a well-known risk factor for pancreatic cancer. The incidence of pancreatic cancer is also increasing and has one of the lowest survival rates of all cancers.

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

GlaxoSmithKline plc and NanoBio Corporation today announced an exclusive licensing agreement in the United States and Canada for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores. Developed by NanoBio, NB-001 provides significant antimicrobial activity against the virus that causes cold sores, herpes labialis.

2-D models may often give researchers misleading results

Imagine millions of cancer cells organized in thousands of small divots. Hit these cells with drugs and when some cells die, you have a candidate for a cancer drug. But a review published this week in the journal Expert Opinion on Drug Discovery argues that these 2D models in fact offer very little information about a potential drug's effects in the body and may often give researchers misleading results.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)